Clinical Trial Update: The Study Of Azithromycin Switch Therapy For Treatment Of Community Acquired Pneumonia (CAP) [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating azithromycin switch therapy for community-acquired pneumonia; the study completed and results were posted in 2011.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Community-acquired Pneumonia

Drugs mentioned

• Azithromycin (azithromycin)

Snippet

Sponsor: Pfizer | Conditions: Community Acquired Pneumonia (CAP) | Phase 3 | Status: COMPLETED | Results posted: 2011-04-13